Treatment for glioblastoma (GBM)
Intended for US audiences only.
JB is an Optune user

In people with recurrent GBM

Proven to provide comparable survival results
without chemotherapy-related side effects

A large clinical study in recurrent GBM showed that Optune was as effective as
chemotherapy, with people self-reporting:

  • Better quality of life

  • Improved cognitive functioning
    (better memory and concentration)

  • Increased emotional functioning
    (less tension and irritability)

Side effects of Optune compared to chemotherapy

Before you start therapy with Optune, you'll want to consider some of the potential benefits and side effects. For people with recurrent GBM, Optune is used alone. Some of the benefits of Optune may vary based on where you are in your diagnosis and treatment plan.

Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Reference:
  1. Optune [Instruction for Use]. Novocure 2016.

Learn how Tumor Treating Fields work

Watch the video

Find an Optune doctor

By ZIP code

What is Optune® approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.

Newly diagnosed GBM

If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:

Recurrent GBM

If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:

Who should not use Optune?

Optune is not for everyone. Talk to your doctor if you have:

Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.

What should I know before using Optune?

Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure™, the maker of Optune.

What are the possible side effects of Optune?

Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.

The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.

Talk to your doctor if you have any of these side effects or questions.


Please click here to see the Optune Instructions for Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.


On this site, patient and healthcare professional videos as well as all images labeled as Optune users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals. All other depictions of patients and caregivers are actor portrayals.

What is Optune approved to treat?

Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.